In humans, mutations in the BRCA1 and BRCA2 genes are strongly associated with an increased risk of breast, ovarian, prostate, pancreatic, melanoma, and peritoneal cancers, highlighting their essential role in DNA repair mechanisms, cell cycle control, and tumor suppression [31,32,33,34,35]. The gene discussed is BRCA1; the disease is neoplasm.